BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24557039)

  • 1. Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.
    Serpente M; Bonsi R; Scarpini E; Galimberti D
    Neuroimmunomodulation; 2014; 21(2-3):79-87. PubMed ID: 24557039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity in Alzheimer's disease.
    Heneka MT; Golenbock DT; Latz E
    Nat Immunol; 2015 Mar; 16(3):229-36. PubMed ID: 25689443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
    Webers A; Heneka MT; Gleeson PA
    Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammation and Alzheimer's disease].
    de Toledo M
    Rev Neurol; 2006 Apr 1-15; 42(7):433-8. PubMed ID: 16602061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
    Bamberger ME; Landreth GE
    Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
    Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
    Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
    Weisman D; Hakimian E; Ho GJ
    Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of immune regulation in Alzheimer's disease: a viewpoint.
    Marx F; Blasko I; Grubeck-Loebenstein B
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):205-9. PubMed ID: 10483867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
    Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
    Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia as a potential bridge between the amyloid beta-peptide and tau.
    Kitazawa M; Yamasaki TR; LaFerla FM
    Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Neuroinflammation to Treat Alzheimer's Disease.
    Ardura-Fabregat A; Boddeke EWGM; Boza-Serrano A; Brioschi S; Castro-Gomez S; Ceyzériat K; Dansokho C; Dierkes T; Gelders G; Heneka MT; Hoeijmakers L; Hoffmann A; Iaccarino L; Jahnert S; Kuhbandner K; Landreth G; Lonnemann N; Löschmann PA; McManus RM; Paulus A; Reemst K; Sanchez-Caro JM; Tiberi A; Van der Perren A; Vautheny A; Venegas C; Webers A; Weydt P; Wijasa TS; Xiang X; Yang Y
    CNS Drugs; 2017 Dec; 31(12):1057-1082. PubMed ID: 29260466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: systemic inflammation and Alzheimer's disease.
    Holmes C
    Neuropathol Appl Neurobiol; 2013 Feb; 39(1):51-68. PubMed ID: 23046210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the peripheral innate immune system in the development of Alzheimer's disease.
    Le Page A; Dupuis G; Frost EH; Larbi A; Pawelec G; Witkowski JM; Fulop T
    Exp Gerontol; 2018 Jul; 107():59-66. PubMed ID: 29275160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity, local inflammation, and degenerative disease.
    McGeer PL; McGeer EG
    Sci Aging Knowledge Environ; 2002 Jul; 2002(29):re3. PubMed ID: 14602998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune attack: the role of inflammation in Alzheimer disease.
    Heppner FL; Ransohoff RM; Becher B
    Nat Rev Neurosci; 2015 Jun; 16(6):358-72. PubMed ID: 25991443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence.
    Eikelenboom P; Veerhuis R; van Exel E; Hoozemans JJ; Rozemuller AJ; van Gool WA
    Curr Alzheimer Res; 2011 Mar; 8(2):142-50. PubMed ID: 21345167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.